-

WHOOP Launches Specialized Panels to Deliver Deeper, More Personalized Health Insights

New $299 targeted blood tests, powered by Quest Diagnostics, expand biomarker testing to key areas like heart health, performance, and metabolic function

BOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, today announced the launch of Specialized Panels, a new line of targeted blood tests designed to deliver deeper insight into specific areas of health. As part of the company’s Advanced Labs offering, Specialized Panels, powered exclusively by Quest Diagnostics in the United States, allow WHOOP members to take blood biomarker testing further, focusing on the categories that matter most to their individual goals.

Specialized Panels are one-time, domain-specific blood tests designed to go deeper on key areas of health, analyzing between 75 and 89 biomarkers across five panels: Heart Health, Performance, Metabolic Health, Women’s Health, and Men’s Health. Each panel is available for a one-time purchase of $299, is FSA/HSA eligible, and does not require a subscription or initial Comprehensive Health Panel.

"The response we've seen since launching Advanced Labs has been exceptional,” said Alex Vannoni, Head of Healthcare Product at WHOOP. “Specialized Panels allow us to take the experience further. We’re empowering our members to choose more bespoke panels that address areas of interest or concern."

WHOOP first entered the blood biomarker space in 2025 with the launch of Advanced Labs, which combined blood biomarker testing with continuous wearable data to create a unified view of health. Specialized Panels represent the next evolution of that platform - giving members the flexibility to move from broad understanding to targeted optimization.

Since the launch of Advanced Labs at the end of last year, WHOOP members have gained a deeper, data-driven understanding of their health at the biomarker level. Early data shows that even among a highly active population, 22% exhibit signs of metabolic dysfunction and nearly 30% have underlying cardiometabolic risk factors, often without prior awareness - underscoring the need for more focused, domain-specific insights.

How It Works

All blood testing for Specialized Panels is performed by Quest Diagnostics, with members able to schedule a blood draw at approximately 2,000 Quest Diagnostics patient service centers within the United States. Members can select a panel based on their area of focus, complete a blood draw, and receive results directly in the WHOOP app. All tests are reviewed and ordered by a licensed healthcare provider.

Results are integrated with continuous WHOOP data – including sleep, strain, and recovery - and translated into personalized insights, clinician-reviewed summaries, and clear, actionable recommendations. This creates a powerful feedback loop between targeted biomarker data and daily behavior.

Together with the WHOOP Advanced Labs Comprehensive Panel, these offerings connect lab testing with continuous biometric data, giving members a deeper and more actionable understanding of their health.

To learn more about Specialized Panels see here. Media kit available here.

About WHOOP

WHOOP delivers a wearable membership to help people live healthier, longer lives and unlock extraordinary potential. Through a powerful 24/7 wearable with a 14-day battery life, WHOOP provides intelligent health guidance across sleep, recovery, strain, fitness, and longevity. The health platform includes an FDA-cleared ECG, a Healthspan longevity feature, Blood Pressure Insights, and Advanced Labs blood biomarker analysis. Research shows that people who wear WHOOP daily log more than 90 additional minutes of exercise per week, get over two extra hours of sleep, and have 10% higher heart rate variability.

Trusted by millions of members worldwide including athletes, global leaders, military operators, executives, and artists, WHOOP has become a modern symbol of disciplined, intentional living. WHOOP was founded in 2012 and is headquartered in Boston. The company has raised more than $900 million in venture capital, ships to 56 countries, and operates in six languages. To learn more or start a one-month free trial, visit whoop.com and connect with WHOOP on Instagram, X, Facebook, LinkedIn, and YouTube.

Contacts

Pippa Doyle
Press@whoop.com

WHOOP


Release Versions

Contacts

Pippa Doyle
Press@whoop.com

More News From WHOOP

WHOOP Makes Advanced Labs Available Without a Wearable Membership

BOSTON--(BUSINESS WIRE)--WHOOP, the human performance brand, today announced it is expanding access to proactive health, adding Galleri®, GRAIL's multi-cancer early detection test and, for the first time, making WHOOP Advanced Labs available without a membership. WHOOP Advanced Labs is powered in the U.S. by Quest Diagnostics (NYSE: DGX). WHOOP Advanced Labs combines comprehensive blood testing, clinician-reviewed results, AI-powered insights, and personalized recommendations to give people a d...

WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership

BOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth c...

WHOOP Names Kyle Leahy Chief Commercial Officer to Scale Premium Distribution and Drive Growth

BOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, today named Kyle Leahy Chief Commercial Officer. Leahy will lead the company’s commercial organization, overseeing global wholesale and retail, partnerships, enterprise, and healthcare go-to-market strategy.Leahy’s appointment comes as WHOOP expands with retailers and e-commerce marketplaces, grows its enterprise business, and builds relationships across healthcare in the United States and internationally.Leahy most recently served a...
Back to Newsroom